182 related articles for article (PubMed ID: 7923098)
1. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers.
Nelson MA; Einspahr JG; Alberts DS; Balfour CA; Wymer JA; Welch KL; Salasche SJ; Bangert JL; Grogan TM; Bozzo PO
Cancer Lett; 1994 Sep; 85(1):23-9. PubMed ID: 7923098
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis.
Kubo Y; Urano Y; Yoshimoto K; Iwahana H; Fukuhara K; Arase S; Itakura M
J Invest Dermatol; 1994 Apr; 102(4):440-4. PubMed ID: 8151121
[TBL] [Abstract][Full Text] [Related]
3. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
4. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients.
Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
Br J Cancer; 1994 Oct; 70(4):662-7. PubMed ID: 7917913
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
[TBL] [Abstract][Full Text] [Related]
7. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
[TBL] [Abstract][Full Text] [Related]
8. From actinic keratosis to squamous cell carcinoma.
Ortonne JP
Br J Dermatol; 2002 Apr; 146 Suppl 61():20-3. PubMed ID: 11966728
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations in skin cancers with underlying disorders.
Kanekura T; Kanzaki T; Kanekura S; Kawahara K; Nakashima T; Kitajima I; Maruyama I
J Dermatol Sci; 1995 May; 9(3):209-14. PubMed ID: 8664219
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutations in human epithelial skin cancers.
Molès JP; Moyret C; Guillot B; Jeanteur P; Guilhou JJ; Theillet C; Basset-Sèguin N
Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutation analysis in porokeratosis and porokeratosis-associated squamous cell carcinoma.
Ninomiya Y; Urano Y; Yoshimoto K; Iwahana H; Sasaki S; Arase S; Itakura M
J Dermatol Sci; 1997 Mar; 14(3):173-8. PubMed ID: 9138474
[TBL] [Abstract][Full Text] [Related]
12. The scientific basis of skin cancer.
Leffell DJ
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 2):18-22. PubMed ID: 10607352
[TBL] [Abstract][Full Text] [Related]
13. p53 protects against skin cancer induction by UV-B radiation.
Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
[TBL] [Abstract][Full Text] [Related]
14. Infrequent p53 mutations in arsenic-related skin lesions.
Castrén K; Ranki A; Welsh JA; Vähäkangas KH
Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
[TBL] [Abstract][Full Text] [Related]
15. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions.
Suzui M; Yoshimi N; Tanaka T; Mori H
Mol Carcinog; 1995 Dec; 14(4):294-8. PubMed ID: 8519419
[TBL] [Abstract][Full Text] [Related]
16. Chronic ultraviolet exposure-induced p53 gene alterations in Sencar mouse skin carcinogenesis model.
Tong Y; Smith MA; Tucker SB
J Toxicol Environ Health; 1997 Jun; 51(3):219-34. PubMed ID: 9183379
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas.
Pierceall WE; Mukhopadhyay T; Goldberg LH; Ananthaswamy HN
Mol Carcinog; 1991; 4(6):445-9. PubMed ID: 1793482
[TBL] [Abstract][Full Text] [Related]
18. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
19. Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in human skin.
Taguchi M; Watanabe S; Yashima K; Murakami Y; Sekiya T; Ikeda S
J Invest Dermatol; 1994 Oct; 103(4):500-3. PubMed ID: 7930674
[TBL] [Abstract][Full Text] [Related]
20. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor.
Mortier L; Marchetti P; Delaporte E; Martin de Lassalle E; Thomas P; Piette F; Formstecher P; Polakowska R; Danzé PM
Cancer Lett; 2002 Feb; 176(2):205-14. PubMed ID: 11804749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
